NACDS shares state-level public opinion on pharmacies and COVID-19Seventy-six percent of voters agree that COVID-19 has shown that public health partners like pharmacies are important and that barriers need to be removed. NCPA survey finds pharmacists facing drug shortages amid pandemicLocal pharmacists are reporting shortages of albuterol inhalers, hydroxychloroquine, azithromycin, and other drugs in high demand since the COVID-19 outbreak, according to a new survey from NCPA. Amneal launches generic Butrans Butrans had a market value of roughly $225 million for the 12 months ended February 2020, according to IQVIA. Mylan's Robert Coury returns as executive chairman Robert Coury returns to Mylan as executive chairman amid the COVID-19 outbreak, and activities needed to close the combination of Mylan and Upjohn. Rutgers University's saliva test for COVID-19 gets FDA emergency use authorization The FDA's approval of Rutgers' saliva collection test will allow for broader population screening of COVID-19 than nose and throat swabs. NACDS praises new Virginia law for increasing patient access, expanding pharmacists' services House Bill 1506 enhances Virginians’ access to pharmacies and empowers pharmacists to provide services. Dr. Reddy's rolls out 2 generics For the year ended January 2020, Nitroglycerin transdermal patch products had a market value of roughly $14.7 million, and the Evekeo brand and generic had a market value of approximately $38 million. Cipla obtains FDA approval for generic Proventil HFA Cipla’s generic albuterol inhaler is the first generic to treat and prevent bronchospasm. Parata Systems launches relief fund for pharmacy employees impacted by COVID-19 Parata Systems and CPS are helping pharmacy employees impacted by COVID-19. AAM cancels Access! 2020 Annual Meeting AAM has cancelled its annual meeting scheduled for May and is looking forward to GRx+Biosims conference in November. First Previous 395 396 397 398 399 Next Last